NO169966C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-substituerte pyrazolo(3,4-d)pyrimidinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-substituerte pyrazolo(3,4-d)pyrimidinderivater

Info

Publication number
NO169966C
NO169966C NO89890894A NO890894A NO169966C NO 169966 C NO169966 C NO 169966C NO 89890894 A NO89890894 A NO 89890894A NO 890894 A NO890894 A NO 890894A NO 169966 C NO169966 C NO 169966C
Authority
NO
Norway
Prior art keywords
preparation
pyrimidine derivatives
therapeutic active
substituted pyrazolo
analogy procedure
Prior art date
Application number
NO89890894A
Other languages
English (en)
Norwegian (no)
Other versions
NO169966B (no
NO890894D0 (no
NO890894L (no
Inventor
Jeffrey B Press
Zoltan Hajos
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO890894D0 publication Critical patent/NO890894D0/no
Publication of NO890894L publication Critical patent/NO890894L/no
Publication of NO169966B publication Critical patent/NO169966B/no
Publication of NO169966C publication Critical patent/NO169966C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO89890894A 1988-03-03 1989-03-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-substituerte pyrazolo(3,4-d)pyrimidinderivater NO169966C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/163,488 US4885300A (en) 1988-03-03 1988-03-03 4-Substituted pyrazolo[3,4-D]pyrimidine derivatives

Publications (4)

Publication Number Publication Date
NO890894D0 NO890894D0 (no) 1989-03-02
NO890894L NO890894L (no) 1989-09-04
NO169966B NO169966B (no) 1992-05-18
NO169966C true NO169966C (no) 1992-08-26

Family

ID=22590219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890894A NO169966C (no) 1988-03-03 1989-03-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-substituerte pyrazolo(3,4-d)pyrimidinderivater

Country Status (15)

Country Link
US (3) US4885300A (fi)
EP (1) EP0331510A3 (fi)
JP (1) JP2567936B2 (fi)
KR (1) KR940002827B1 (fi)
CN (1) CN1030605C (fi)
AU (1) AU612797B2 (fi)
DK (1) DK101689A (fi)
FI (1) FI92202C (fi)
HU (1) HU204274B (fi)
IL (1) IL89459A (fi)
NO (1) NO169966C (fi)
NZ (1) NZ228168A (fi)
PH (1) PH25999A (fi)
PT (1) PT89904B (fi)
ZA (1) ZA891620B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712735A1 (de) * 1987-04-15 1988-11-10 Boehringer Mannheim Gmbh Neue pyrazolo(3,4-d)pyrimidine, verfahren zu ihrer herstellung und verwendung als arzneimittel
EP0440515B1 (en) * 1990-01-30 1995-08-23 Visa International Service Association International authorization system
JP2651043B2 (ja) * 1990-07-10 1997-09-10 麒麟麦酒株式会社 ジフェニルメチルピペラジン誘導体
US5646152A (en) * 1994-06-15 1997-07-08 Pfizer Inc. Methods of administering CRF antagonists
AU4219897A (en) * 1996-09-18 1998-04-14 Daiso Co. Ltd. Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers
CA2263267C (en) * 1996-09-18 2006-05-02 Daiso Co., Ltd. Process for the preparation of glycidyl ethers
CN106070266B (zh) * 2016-06-29 2018-11-30 贵州大学 吡唑[3,4-d]嘧啶酮席夫碱类化合物在制备抗植物病毒剂中的应用
US10927084B2 (en) * 2017-01-26 2021-02-23 Tosoh Corporation Alkanolamine, friction-reducing agent, and lubricating oil composition
CA3068254A1 (en) 2017-06-20 2018-12-27 Imbria Pharmaceuticals, Inc. Compositions and methods for increasing efficiency of cardiac metabolism
US11530184B2 (en) 2020-06-30 2022-12-20 Imbria Pharmaceuticals, Inc. Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11780811B2 (en) 2020-06-30 2023-10-10 Imbria Pharmaceuticals, Inc. Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11883396B2 (en) 2021-05-03 2024-01-30 Imbria Pharmaceuticals, Inc. Methods of treating kidney conditions using modified forms of trimetazidine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139705A (en) * 1977-05-20 1979-02-13 The Dow Chemical Company Pyrazolopyrimidines
FR2431710A1 (fr) * 1978-07-18 1980-02-15 Elf Aquitaine Procede d'exploration sismique par diagraphie acoustique
DE3200304A1 (de) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel
DE3131365A1 (de) * 1981-08-07 1983-02-24 Henkel KGaA, 4000 Düsseldorf Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
US4460303A (en) * 1982-07-29 1984-07-17 Ingersoll-Rand Company Drill pipe loader
US4603203A (en) * 1983-12-14 1986-07-29 Takeda Chemical Industries, Ltd. 3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof
DE3423092A1 (de) * 1984-06-22 1986-01-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel
HU198052B (en) * 1986-02-14 1989-07-28 Sandoz Ag Process for producing purine derivatives substituted by side chain containing piperazinyl ring and pharmaceutical compositions comprising such compounds
US4876257A (en) * 1988-03-03 1989-10-24 Ortho Pharmaceutical Corporation 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents

Also Published As

Publication number Publication date
FI92202B (fi) 1994-06-30
IL89459A (en) 1993-04-04
DK101689A (da) 1989-09-04
FI92202C (fi) 1994-10-10
IL89459A0 (en) 1989-09-10
CN1036766A (zh) 1989-11-01
JPH01279890A (ja) 1989-11-10
PH25999A (en) 1992-01-13
EP0331510A3 (en) 1991-03-13
DK101689D0 (da) 1989-03-02
PT89904A (pt) 1989-11-10
EP0331510A2 (en) 1989-09-06
NO169966B (no) 1992-05-18
US4885300A (en) 1989-12-05
ZA891620B (en) 1990-11-28
KR940002827B1 (ko) 1994-04-04
FI891004A0 (fi) 1989-03-02
KR890014542A (ko) 1989-10-24
FI891004A (fi) 1989-09-04
NO890894D0 (no) 1989-03-02
NZ228168A (en) 1991-07-26
AU612797B2 (en) 1991-07-18
US5001127A (en) 1991-03-19
AU3088389A (en) 1989-09-07
USRE35072E (en) 1995-10-24
NO890894L (no) 1989-09-04
CN1030605C (zh) 1996-01-03
HUT49353A (en) 1989-09-28
HU204274B (en) 1991-12-30
JP2567936B2 (ja) 1996-12-25
PT89904B (pt) 1994-11-30

Similar Documents

Publication Publication Date Title
NO171272C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,4-triazolforbindelser
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO895086L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO903088L (no) Fremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
NO862956L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
NO164542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)-pyrimidinderivater.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO871044L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO169966C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-substituerte pyrazolo(3,4-d)pyrimidinderivater
NO171067C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro- og 4,5,6,7-tetrahydro-pyrazolo (1,5-a)pyrimidiner
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO167028C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo(3,4-d)pyrimidinderivater
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO891114D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO884175D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO166128C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(1,2-a)pyridinderivater.